Virender Kumar, Ph.D.

Dr. KumarPostdoctoral Research Associate

Department of Pharmaceutical Sciences
College of Pharmacy
University of Nebraska Medical Center
985965 Nebraska Medical Center
Omaha, NE 68198-5965
(402) 559-6987


2016 - Ph.D., UNMC, Omaha, NE
2009 - Masters in Industrial Pharmacy, St. John's University, NY
2005 - Masters in Pharmaceutics, Guru Jambheshwar University,  Hissar, India
2005 - B.Pharm., Guru Jambheshwar University,  Hissar, India

Research Interests

Synthesis and characterization of polyester/lipid based particulate systems for stabilization improving in-vivo delivery of hydrophobic small drug molecules and oligonucleotides (siRNAs, miRNAs).


  1. Kumar V, Mondal G, Dutta R, Mahato R., Co-delivery of Small Molecule Hedgehog Inhibitor and miRNA for treating Liver Fibrosis. Biomaterials, 2016 Jan; 76:144-56.
  2. Mondal G, Kumar V, Shukla SK, Singh PK, Mahato RI, EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2015 Dec 17. [Epub ahead of print].
  3. Mundra V, Peng Y, Kumar V, Li W, Miller DD, Mahato RI., Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma. Drug Deliv Transl Res. 2015 Jun; 5(3):199-208.
  4. Kumar V, Mondal G, Slavik P, Rachagani S, Batra SK, Mahato RI., Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer. Mol Pharm. 2015 Apr 6; 12(4):1289-98.
  5. Kumar V, Mahato RI. Delivery and Targeting of miRNAs for Treating Liver Fibrosis. Pharm Res. 2015 Feb;32(2):341-6
  6. Kumar V, Mundra V, Mahato RI., Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis. Pharm Res. 2014 May; 31(5):1158-69.
  7. Singh S, Chitkara D, Kumar V, Behrman SW, Mahato R. miRNA Profiling in Pancreatic Cancer and Restoration of Chemosensitivity. Cancer Lett. 2013 Jul 1; 334(2):211-20.
  8. Chitkara D, Singh S, Kumar V, Danquah M, Behrman SW, Kumar N, Mahato RI. Micellar Delivery of Cyclopamine and Gefitinib for Treating Pancreatic Cancer. Mol Pharm. 2012 Aug 6; 9(8):2350-7.